Engineering strategies to mimic the glioblastoma microenvironment

Advanced Drug Delivery Reviews

Volumn 79, Issue , 2014, Pages 172-183

  Rape, Andrew ^a   Ananthanarayanan, Badriprasad ^a   Kumar, Sanjay ^a  

^a University of California   (United States)

Author keywords

Biomaterials; Extracellular matrix; Glioblastoma; Invasion; Microenvironment; Motility; Tumor engineering

Indexed keywords

BIOMATERIALS; BLOOD VESSELS; CELLS; CYTOLOGY; SCAFFOLDS (BIOLOGY); TUMORS;

EXTRACELLULAR MATRICES; GLIOBLASTOMAS; INVASION; MICROENVIRONMENTS; MOTILITY;

DIAGNOSIS;

BIOMATERIAL; BIOPOLYMER; COLLAGEN; FIBRONECTIN; GLYCOSAMINOGLYCAN; HERMES ANTIGEN; INTERLEUKIN 8; LAMININ; MATRIX METALLOPROTEINASE; RAC1 PROTEIN; RANTES; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SCLEROPROTEIN;

ASTROCYTE; BIOENGINEERING; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURVIVAL; CELL INFILTRATION; CELL INTERACTION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; GLIOBLASTOMA; HIGH THROUGHPUT SCREENING; HYDROGEL; IN VITRO STUDY; MICROGLIA; MICROTECHNOLOGY; MYELINATION; NERVE FIBER; PHENOTYPE; POLYMERIZATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE; SURVIVAL TIME; TUMOR CELL; TUMOR ENGINEERING; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ANIMAL; BIOLOGICAL MODEL; BRAIN TUMOR; HUMAN; METABOLISM; MOLECULAR BIOLOGY; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SURVIVAL RATE; SYSTEMS BIOLOGY; TISSUE ENGINEERING;

ANIMALS; BRAIN NEOPLASMS; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR BIOLOGY; SURVIVAL RATE; SYSTEMS BIOLOGY; TISSUE ENGINEERING; TUMOR MICROENVIRONMENT;

EID: 84919650367     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2014.08.012     Document Type: Review

References (189)

1. Agnihotri S., Burrell K.E., Wolf A., Jalali S., Hawkins C., et al. Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies. Arch. Immunol. Ther. Exp. 2013, 61:25-41. 10.1007/s00005-012-0203-0.
2. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114:97-109. 10.1007/s00401-007-0243-4.
3. Dandy W.E. Removal of right cerebral hemisphere for certain tumors with hemiplegia: Preliminary report. JAMA 1928, 90:823-825. 10.1001/jama.1928.02690380007003.
4. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352:987-996. 10.1056/NEJMoa043330.
5. Berens M.E., Giese A. ". . .Those left behind". Biology and oncology of invasive glioma cells. Neoplasia 1999, 1:208-219.
6. McLendon R., Friedman A., Bigner D., Meir E.G.V., Brat D.J., et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068. 10.1038/nature07385.
7. Verhaak R.G.W., Hoadley K.A., Purdom E., Wang V., Qi Y., et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17:98-110. 10.1016/j.ccr.2009.12.020.
8. Altaner C. Glioblastoma and stem cells. Neoplasma 2008, 55:369-374.
9. Albini A., Sporn M.B. The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer 2007, 7:139-147. 10.1038/nrc2067.
10. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239-252. 10.1038/nrc2618.
11. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254. 10.1016/j.ccr.2005.08.010.
12. Chinot O.L., de LM Rouge T., Moore N., Zeaiter A., Das A., et al. AVAglio: phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme. Adv. Ther. 2011, 28:334-340. 10.1007/s12325-011-0007-3.
13. Kreisl T.N., Kim L., Moore K., Duic P., Royce C., et al. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J. Clin. Oncol. 2009, 27:740-745. 10.1200/JCO.2008.16.3055.
14. Narayana A., Gruber D., Kunnakkat S., Golfinos J.G., Parker E., et al. A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma: clinical article. J. Neurosurg. 2012, 116:341-345. 10.3171/2011.9.JNS11656.
15. Vredenburgh J.J., Desjardins A., Herndon J.E., Dowell J.M., Reardon D.A., et al. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin. Cancer Res. 2007, 13:1253-1259. 10.1158/1078-0432.CCR-06-2309.
16. Jain A., Betancur M., Patel G.D., Valmikinathan C.M., Mukhatyar V.J., et al. Guiding intracortical brain tumour cells to an extracortical cytotoxic hydrogel using aligned polymeric nanofibres. Nat. Mater. 2014, 13:308-316. 10.1038/nmat3878.
17. Charles N.A., Holland E.C., Gilbertson R., Glass R., Kettenmann H. The brain tumor microenvironment. Glia 2011, 59:1169-1180. 10.1002/glia.21136.
18. Payne L.S., Huang P. The pathobiology of collagens in glioma. Mol. Cancer Res. 2013, 11(10):1129-1140.
19. Ulrich T., Kumar S. Mechanobiology in health and disease in the central nervous system. Mechanobiology handbook 2011, 391-411. CRC Press, (Available: http://www.crcnetbase.com/doi/abs/10.1201/b10780-23. Accessed 14 August 2013). J. Nagatomi (Ed.).
20. Laurent T.C., Fraser J.R. Hyaluronan. FASEB J. 1992, 6:2397-2404.
21. Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 2004, 4:528-539. 10.1038/nrc1391.
22. Delpech B., Maingonnat C., Girard N., Chauzy C., Maunoury R., et al. Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumour stroma. Eur. J. Cancer 1993, 29A:1012-1017.
23. Wiranowska M., Ladd S., Moscinski L.C., Hill B., Haller E., et al. Modulation of hyaluronan production by CD44 positive glioma cells. Int. J. Cancer 2010, 127:532-542. 10.1002/ijc.25085.
24. Ariza A., López D., Mate J.L., Isamat M., Musulén E., et al. Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study. Hum. Pathol. 1995, 26:1144-1147.
25. Wiranowska M., Ladd S., Smith S.R., Gottschall P.E. CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma. Brain Cell Biol. 2006, 35:159-172. 10.1007/s11068-007-9009-0.
26. Bourguignon L.Y.W. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin. Cancer Biol. 2008, 18:251-259. 10.1016/j.semcancer.2008.03.007.
27. Bourguignon L.Y., Zhu H., Shao L., Chen Y.W. CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J. Biol. Chem. 2000, 275:1829-1838.
28. Herishanu Y., Gibellini F., Njuguna N., Hazan-Halevy I., Keyvanfar K., et al. CD44 signaling via PI3K/AKT and MAPK/ERK pathways protects CLL cells from spontaneous and drug induced apoptosis through MCL-1. Leuk. Lymphoma 2011, 52:1758-1769. 10.3109/10428194.2011.569962.
29. Novak U., Stylli S.S., Kaye A.H., Lepperdinger G. Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells. Cancer Res. 1999, 59:6246-6250.
30. Giese A., Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996, 39:235-250. (discussion 250-252).
31. Knott J.C., Mahesparan R., Garcia-Cabrera I., Bølge Tysnes B., Edvardsen K., et al. Stimulation of extracellular matrix components in the normal brain by invading glioma cells. Int. J. Cancer 1998, 75:864-872.
32. Tysnes B.B., Mahesparan R., Thorsen F., Haugland H.K., Porwol T., et al. Laminin expression by glial fibrillary acidic protein positive cells in human gliomas. Int. J. Dev. Neurosci. 1999, 17:531-539.
33. Yamamoto M., Mohanam S., Sawaya R., Fuller G.N., Seiki M., et al. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res. 1996, 56:384-392.
34. Demuth T., Berens M.E. Molecular mechanisms of glioma cell migration and invasion. J. Neurooncol. 2004, 70:217-228. 10.1007/s11060-004-2751-6.
35. Kaufman L.J., Brangwynne C.P., Kasza K.E., Filippidi E., Gordon V.D., et al. Glioma expansion in collagen I matrices: analyzing collagen concentration-dependent growth and motility patterns. Biophys. J. 2005, 89:635-650. 10.1529/biophysj.105.061994.
36. Kawataki T., Yamane T., Naganuma H., Rousselle P., Andurén I., et al. Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness: Evidence for a role of alpha5-laminin(s) and alpha3beta1 integrin. Exp. Cell Res. 2007, 313:3819-3831. 10.1016/j.yexcr.2007.07.038.
37. Lathia J.D., Li M., Hall P.E., Gallagher J., Hale J.S., et al. Laminin alpha 2 enables glioblastoma stem cell growth. Ann. Neurol. 2012, 72:766-778. 10.1002/ana.23674.
38. Ohnishi T., Hiraga S., Izumoto S., Matsumura H., Kanemura Y., et al. Role of fibronectin-stimulated tumor cell migration in glioma invasion in vivo: clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues. Clin. Exp. Metastasis 1998, 16:729-741.
39. Mahesparan R., Read T.-A., Lund-Johansen M., Skaftnesmo K.O., Bjerkvig R., et al. Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol. 2003, 105:49-57. 10.1007/s00401-002-0610-0.
40. Zagzag D., Friedlander D.R., Miller D.C., Dosik J., Cangiarella J., et al. Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res. 1995, 55:907-914.
41. Hehlgans S., Haase M., Cordes N. Signalling via integrins: implications for cell survival and anticancer strategies. Biochim. Biophys. Acta 2007, 1775:163-180. 10.1016/j.bbcan.2006.09.001.
42. Aoudjit F., Vuori K. Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene 2001, 20:4995-5004. 10.1038/sj.onc.1204554.
43. Lathia J.D., Gallagher J., Heddleston J.M., Wang J., Eyler C.E., et al. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 2010, 6:421-432. 10.1016/j.stem.2010.02.018.
44. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67. 10.1016/j.cell.2010.03.015.
45. Rao J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 2003, 3:489-501. 10.1038/nrc1121.
46. Discher D.E., Janmey P., Wang Y. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310:1139-1143. 10.1126/science.1116995.
47. Oakes P.W., Beckham Y., Stricker J., Gardel M.L. Tension is required but not sufficient for focal adhesion maturation without a stress fiber template. J. Cell Biol. 2012, 196:363-374. 10.1083/jcb.201107042.
48. Kolega J., Janson L.W., Taylor D.L. The role of solation-contraction coupling in regulating stress fiber dynamics in nonmuscle cells. J. Cell Biol. 1991, 114:993-1003.
49. Chang C.-W., Kumar S. Vinculin tension distributions of individual stress fibers within cell-matrix adhesions. J. Cell Sci. 2013, 126:3021-3030. 10.1242/jcs.119032.
50. Geiger B., Bershadsky A. Assembly and mechanosensory function of focal contacts. Curr. Opin. Cell Biol. 2001, 13:584-592.
51. Solon J., Levental I., Sengupta K., Georges P.C., Janmey P.A. Fibroblast adaptation and stiffness matching to soft elastic substrates. Biophys. J. 2007, 93:4453-4461. 10.1529/biophysj.106.101386.
52. Pelham R.J., Wang Y. Cell locomotion and focal adhesions are regulated by substrate flexibility. PNAS 1997, 94:13661-13665.
53. Maniotis A.J., Chen C.S., Ingber D.E. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. PNAS 1997, 94:849-854.
54. Selbekk T., Brekken R., Solheim O., Lydersen S., Hernes T.A.N., et al. Tissue motion and strain in the human brain assessed by intraoperative ultrasound in glioma patients. Ultrasound Med. Biol. 2010, 36:2-10. 10.1016/j.ultrasmedbio.2009.05.007.
55. Elkin B.S., Azeloglu E.U., Costa K.D., Morrison B. Mechanical heterogeneity of the rat hippocampus measured by atomic force microscope indentation. J. Neurotrauma 2007, 24:812-822. 10.1089/neu.2006.0169.
56. Lefranc F., Brotchi J., Kiss R. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J. Clin. Oncol. 2005, 23:2411-2422. 10.1200/JCO.2005.03.089.
57. Scherer H. Structural development in gliomas. Am. J. Cancer 1938, 34:333-348.
58. Scherer H.J. The forms of growth in gliomas and their practical significance. Brain 1940, 63:1-35. 10.1093/brain/63.1.1.
59. Rutka J.T., Muller M., Hubbard S.L., Forsdike J., Dirks P.B., et al. Astrocytoma adhesion to extracellular matrix: functional significance of integrin and focal adhesion kinase expression. J. Neuropathol. Exp. Neurol. 1999, 58:198-209.
60. Belot N., Rorive S., Doyen I., Lefranc F., Bruyneel E., et al. Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features. Glia 2001, 36:375-390.
61. Friedlander D.R., Zagzag D., Shiff B., Cohen H., Allen J.C., et al. Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins. Cancer Res. 1996, 56:1939-1947.
62. Paulus W., Baur I., Schuppan D., Roggendorf W. Characterization of integrin receptors in normal and neoplastic human brain. Am. J. Pathol. 1993, 143:154-163.
63. Boucher Y., Salehi H., Witwer B., Harsh G.R., Jain R.K. Interstitial fluid pressure in intracranial tumours in patients and in rodents. Br. J. Cancer 1997, 75:829-836.
64. Jain R.K., di Tomaso E., Duda D.G., Loeffler J.S., Sorensen A.G., et al. Angiogenesis in brain tumours. Nat. Rev. Neurosci. 2007, 8:610-622. 10.1038/nrn2175.
65. Polacheck W.J., German A.E., Mammoto A., Ingber D.E., Kamm R.D. Mechanotransduction of fluid stresses governs 3D cell migration. PNAS 2014, (201316848). 10.1073/pnas.1316848111.
66. Wen P.Y., Kesari S. Malignant gliomas in adults. N. Engl. J. Med. 2008, 359:492-507. 10.1056/NEJMra0708126.
67. Song S., Ewald A.J., Stallcup W., Werb Z., Bergers G. PDGFRbeta+perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat. Cell Biol. 2005, 7:870-879. 10.1038/ncb1288.
68. Chekenya M., Enger P.Ø., Thorsen F., Tysnes B.B., Al-Sarraj S., et al. The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours. Neuropathol. Appl. Neurobiol. 2002, 28:367-380.
69. Barbero S., Bajetto A., Bonavia R., Porcile C., Piccioli P., et al. Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro. Ann. N. Y. Acad. Sci. 2002, 973:60-69.
70. Hoelzinger D.B., Demuth T., Berens M.E. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J. Natl. Cancer Inst. 2007, 99:1583-1593. 10.1093/jnci/djm187.
71. Emdad L., Sarkar D., Su Z.-Z., Lee S.-G., Kang D.-C., et al. Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol. Ther. 2007, 114:155-170. 10.1016/j.pharmthera.2007.01.010.
72. Rempel S.A., Dudas S., Ge S., Gutiérrez J.A. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin. Cancer Res. 2000, 6:102-111.
73. Zhou Y., Larsen P.H., Hao C., Yong V.W. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J. Biol. Chem. 2002, 277:49481-49487. 10.1074/jbc.M206222200.
74. Lal P.G., Ghirnikar R.S., Eng L.F. Astrocyte-astrocytoma cell line interactions in culture. J. Neurosci. Res. 1996, 44:216-222. 10.1002/(SICI)1097-4547(19960501)44:3<216::AID-JNR2>3.0.CO;2-J.
75. Couldwell W.T., Yong V.W., Dore-Duffy P., Freedman M.S., Antel J.P. Production of soluble autocrine inhibitory factors by human glioma cell lines. J. Neurol. Sci. 1992, 110:178-185.
76. Le D.M., Besson A., Fogg D.K., Choi K.-S., Waisman D.M., et al. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. J. Neurosci. 2003, 23:4034-4043.
77. Gilbertson R.J., Rich J.N. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat. Rev. Cancer 2007, 7:733-736. 10.1038/nrc2246.
78. Mirzadeh Z., Merkle F.T., Soriano-Navarro M., Garcia-Verdugo J.M., Alvarez-Buylla A. Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain. Cell Stem Cell 2008, 3:265-278. 10.1016/j.stem.2008.07.004.
79. Shen Q., Wang Y., Kokovay E., Lin G., Chuang S.-M., et al. Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions. Cell Stem Cell 2008, 3:289-300. 10.1016/j.stem.2008.07.026.
80. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007, 11:69-82. 10.1016/j.ccr.2006.11.020.
81. Hambardzumyan D., Becher O.J., Rosenblum M.K., Pandolfi P.P., Manova-Todorova K., et al. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev. 2008, 22:436-448. 10.1101/gad.1627008.
82. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 2006, 66:7843-7848. 10.1158/0008-5472.CAN-06-1010.
83. Farin A., Suzuki S.O., Weiker M., Goldman J.E., Bruce J.N., et al. Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia 2006, 53:799-808. 10.1002/glia.20334.
84. Charles N., Ozawa T., Squatrito M., Bleau A.-M., Brennan C.W., et al. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 2010, 6:141-152. 10.1016/j.stem.2010.01.001.
85. Infanger D.W., Cho Y., Lopez B.S., Mohanan S., Liu S.C., et al. Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche. Cancer Res. 2013, 73:7079-7089. 10.1158/0008-5472.CAN-13-1355.
86. Ricci-Vitiani L., Pallini R., Biffoni M., Todaro M., Invernici G., et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010, 468:824-828. 10.1038/nature09557.
87. Soda Y., Marumoto T., Friedmann-Morvinski D., Soda M., Liu F., et al. Transdifferentiation of glioblastoma cells into vascular endothelial cells. PNAS 2011, 108(11):4274-4280.
88. Wang R., Chadalavada K., Wilshire J., Kowalik U., Hovinga K.E., et al. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010, 468:829-833. 10.1038/nature09624.
89. Graeber M.B., Scheithauer B.W., Kreutzberg G.W. Microglia in brain tumors. Glia 2002, 40:252-259. 10.1002/glia.10147.
90. Watters J.J., Schartner J.M., Badie B. Microglia function in brain tumors. J. Neurosci. Res. 2005, 81:447-455. 10.1002/jnr.20485.
91. Bettinger I., Thanos S., Paulus W. Microglia promote glioma migration. Acta Neuropathol. 2002, 103:351-355. 10.1007/s00401-001-0472-x.
92. Markovic D.S., Glass R., Synowitz M., van Rooijen N., Kettenmann H. Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J. Neuropathol. Exp. Neurol. 2005, 64:754-762.
93. Galarneau H., Villeneuve J., Gowing G., Julien J.-P., Vallières L. Increased glioma growth in mice depleted of macrophages. Cancer Res. 2007, 67:8874-8881. 10.1158/0008-5472.CAN-07-0177.
94. Giese A., Loo M.A., Rief M.D., Tran N., Berens M.E. Substrates for astrocytoma invasion. Neurosurgery 1995, 37:294-301.
95. Koochekpour S., Pilkington G.J., Merzak A. Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro. Int. J. Cancer 1995, 63:450-454.
96. Belien A.T.J., Paganetti P.A., Schwab M.E. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J. Cell Biol. 1999, 144:373-384. 10.1083/jcb.144.2.373.
97. Griffith L.G., Swartz M.A. Capturing complex 3D tissue physiology in vitro. Nat. Rev. Mol. Cell Biol. 2006, 7:211-224. 10.1038/nrm1858.
98. Yamada K.M., Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007, 130:601-610. 10.1016/j.cell.2007.08.006.
99. Wilson W.R., Hay M.P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 2011, 11:393-410. 10.1038/nrc3064.
100. Trédan O., Galmarini C.M., Patel K., Tannock I.F. Drug resistance and the solid tumor microenvironment. J. Natl. Cancer Inst. 2007, 99:1441-1454. 10.1093/jnci/djm135.
101. Lo C.-M., Wang H.-B., Dembo M., Wang Y. Cell movement is guided by the rigidity of the substrate. Biophys. J. 2000, 79:144-152. 10.1016/S0006-3495(00)76279-5.
102. Cretu A., Castagnino P., Assoian R. Studying the effects of matrix stiffness on cellular function using acrylamide-based hydrogels 2010, (e2089).
103. Engler A., Bacakova L., Newman C., Hategan A., Griffin M., et al. Substrate compliance versus ligand density in cell on gel responses. Biophys. J. 2004, 86:617-628.
104. Johnson K.R., Leight J.L., Weaver V.M. Demystifying the effects of a three-dimensional microenvironment in tissue morphogenesis. Methods Cell Biol. 2007, 83:547-583. 10.1016/s0091-679x(07)83023-8.
105. Yeung T., Georges P.C., Flanagan L.A., Marg B., Ortiz M., et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil. Cytoskeleton 2005, 60:24-34. 10.1002/cm.20041.
106. Ulrich T.A., de Juan Pardo E.M., Kumar S. The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells. Cancer Res. 2009, 69:4167-4174. 10.1158/0008-5472.CAN-08-4859.
107. Sen S., Dong M.M., Kumar S. Isoform-specific contributions of alpha-actinin to glioma cell mechanobiology. PLoS ONE 2009, 4:e8427. 10.1371/journal.pone.0008427.
108. Sen S., Ng W.P., Kumar S. Contributions of talin-1 to glioma cell-matrix tensional homeostasis. J. R. Soc. Interface 2011, 9(71):1311-1317.
109. MacKay J., Keung A., Kumar S. A genetic strategy for the dynamic and graded control of cell mechanics, motility, and matrix remodeling. Biophys. J. 2012, 102:434-442. 10.1016/j.bpj.2011.12.048.
110. Trappmann B., Gautrot J.E., Connelly J.T., Strange D.G.T., Li Y., et al. Extracellular-matrix tethering regulates stem-cell fate 2012, 642-649.
111. Ananthanarayanan B., Kim Y., Kumar S. Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform. Biomaterials 2011, 32:7913-7923. 10.1016/j.biomaterials.2011.07.005.
112. Fu J., Wang Y.-K., Yang M.T., Desai R.A., Yu X., et al. Mechanical regulation of cell function with geometrically modulated elastomeric substrates. Nat. Methods 2010, 7:733-736. 10.1038/nmeth.1487.
113. Beadle C., Assanah M.C., Monzo P., Vallee R., Rosenfeld S.S., et al. The role of myosin II in glioma invasion of the brain. Mol. Biol. Cell 2008, 19:3357-3368. 10.1091/mbc.E08-03-0319.
114. Ivkovic S., Beadle C., Noticewala S., Massey S.C., Swanson K.R., et al. Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens. Mol. Biol. Cell 2012, 23:533-542. 10.1091/mbc.E11-01-0039.
115. Cukierman E. Taking cell-matrix adhesions to the third dimension. Science 2001, 294:1708-1712. 10.1126/science.1064829.
116. Lu P., Weaver V.M., Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 2012, 196:395-406. 10.1083/jcb.201102147.
117. Gordon V.D., Valentine M.T., Gardel M.L., Andor-Ardó D., Dennison S., et al. Measuring the mechanical stress induced by an expanding multicellular tumor system: a case study. Exp. Cell Res. 2003, 289:58-66. 10.1016/S0014-4827(03)00256-8.
118. Hegedus B., Marga F., Jakab K., Sharpe-Timms K.L., Forgacs G. The interplay of cell-cell and cell-matrix interactions in the invasive properties of brain tumors. Biophys. J. 2006, 91:2708-2716. 10.1529/biophysj.105.077834.
119. Kim H.D., Guo T.W., Wu A.P., Wells A., Gertler F.B., et al. Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence. Mol. Biol. Cell 2008, 19:4249-4259. 10.1091/mbc.E08-05-0501.
120. Yang Y., Motte S., Kaufman L.J. Pore size variable type I collagen gels and their interaction with glioma cells. Biomaterials 2010, 31:5678-5688. 10.1016/j.biomaterials.2010.03.039.
121. Thorne R.G., Nicholson C. In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:5567-5572. 10.1073/pnas.0509425103.
122. Seliktar D. Designing cell-compatible hydrogels for biomedical applications. Science 2012, 336:1124-1128. 10.1126/science.1214804.
123. Lutolf M.P., Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 2005, 23:47-55. 10.1038/nbt1055.
124. Ulrich T.A., Jain A., Tanner K., MacKay J.L., Kumar S. Probing cellular mechanobiology in three-dimensional culture with collagen-agarose matrices. Biomaterials 2010, 31:1875-1884. 10.1016/j.biomaterials.2009.10.047.
125. Ulrich T.A., Lee T.G., Shon H.K., Moon D.W., Kumar S. Microscale mechanisms of agarose-induced disruption of collagen remodeling. Biomaterials 2011, 32:5633-5642. 10.1016/j.biomaterials.2011.04.045.
126. Sahai E., Marshall C.J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat. Cell Biol. 2003, 5:711-719.
127. Wolf K., Mazo I., Leung H., Engelke K., von Andrian U.H., et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 2003, 160:267-277. 10.1083/jcb.200209006.
128. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 2003, 3:362-374. 10.1038/nrc1075.
129. Marklein R.A., Burdick J.A. Spatially controlled hydrogel mechanics to modulate stem cell interactions. Soft Matter 2010, 6:136. 10.1039/b916933d.
130. Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 2003, 4:33-45. 10.1038/nrm1004.
131. Xu Y., Stamenkovic I., Yu Q. CD44 attenuates activation of the Hippo signaling pathway and is a prime therapeutic target for glioblastoma. Cancer Res. 2010, 70:2455-2464. 10.1158/0008-5472.can-09-2505.
132. Khademhosseini A., Langer R., Borenstein J., Vacanti J.P. Microscale technologies for tissue engineering and biology. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2480-2487. 10.1073/pnas.0507681102.
133. Ross A.M., Jiang Z.X., Bastmeyer M., Lahann J. Physical aspects of cell culture substrates: topography, roughness, and elasticity. Small 2012, 8:336-355. 10.1002/smll.201100934.
134. Polacheck W.J., Zervantonakis I.K., Kamm R.D. Tumor cell migration in complex microenvironments. Cell. Mol. Life Sci. 2013, 70:1335-1356. 10.1007/s00018-012-1115-1.
135. Zhu B.S., Zhang Q.Q., Lu Q.H., Xu Y.H., Yin J., et al. Nanotopographical guidance of C6 glioma cell alignment and oriented growth. Biomaterials 2004, 25:4215-4223. 10.1016/j.biomaterials.2003.11.020.
136. Gallego-Perez D., Higuita-Castro N., Denning L., DeJesus J., Dahl K., et al. Microfabricated mimics of in vivo structural cues for the study of guided tumor cell migration. Lab Chip 2012, 12:4424-4432. 10.1039/c2lc40726d.
137. Pathak A., Kumar S. Independent regulation of tumor cell migration by matrix stiffness and confinement. PNAS 2012, 109(26):10334-10339.
138. Pathak A., Kumar S. Transforming potential and matrix stiffness co-regulate confinement sensitivity of tumor cell migration. Integr. Biol. (Camb.) 2013, 5:1067-1075. 10.1039/c3ib40017d.
139. Mammoto T., Jiang A., Jiang E., Panigrahy D., Kieran M.W., et al. Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression. Am. J. Pathol. 2013, 183(4):1293-1305.
140. Sharpless N.E., Depinho R.A. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat. Rev. Drug Discov. 2006, 5:741-754. 10.1038/nrd2110.
141. Johnson J.I., Decker S., Zaharevitz D., Rubinstein L.V., Venditti J.M., et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br. J. Cancer 2001, 84:1424-1431. 10.1054/bjoc.2001.1796.
142. Hutmacher D.W. Biomaterials offer cancer research the third dimension. Nat. Mater. 2010, 9:90-93. 10.1038/nmat2619.
143. Fischbach C., Chen R., Matsumoto T., Schmelzle T., Brugge J.S., et al. Engineering tumors with 3D scaffolds. Nat. Methods 2007, 4:855-860. 10.1038/nmeth1085.
144. Liu Y., Shu X.Z., Prestwich G.D. Tumor engineering: orthotopic cancer models in mice using cell-loaded, injectable, cross-linked hyaluronan-derived hydrogels. Tissue Eng. 2007, 13:1091-1101.
145. Bravo-Cordero J.J., Hodgson L., Condeelis J. Directed cell invasion and migration during metastasis. Curr. Opin. Cell Biol. 2012, 24:277-283. 10.1016/j.ceb.2011.12.004.
146. Wells A., Grahovac J., Wheeler S., Ma B., Lauffenburger D. Targeting tumor cell motility as a strategy against invasion and metastasis. Trends Pharmacol. Sci. 2013, 34:283-289. 10.1016/j.tips.2013.03.001.
147. Hirata E., Yukinaga H., Kamioka Y., Arakawa Y., Miyamoto S., et al. In vivo fluorescence resonance energy transfer imaging reveals differential activation of Rho-family GTPases in glioblastoma cell invasion. J. Cell Sci. 2012, 125:858-868. 10.1242/jcs.089995.
148. Friedl P., Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147:992-1009.
149. Friedl P., Wolf K. Plasticity of cell migration: a multiscale tuning model. J. Cell Biol. 2009, 188:11-19. 10.1083/jcb.200909003.
150. Petrie R.J., Yamada K.M. At the leading edge of three-dimensional cell migration. J. Cell Sci. 2013, 125(25):5917-5926.
151. Ruiz-Ontanon P., Orgaz J.L., Aldaz B., Elosegui-Artola A., Martino J., et al. Cellular plasticity confers migratory and invasive advantages to a population of glioblastoma-initiating cells that infiltrate peritumoral tissue. Stem Cells 2013, 31:1075-1085. 10.1002/stem.1349.
152. Weeks A., Okolowsky N., Golbourn B., Ivanchuk S., Smith C., et al. ECT2 and RASAL2 mediate mesenchymal-amoeboid transition in human astrocytoma cells. Am. J. Pathol. 2012, 181:662-674. 10.1016/j.ajpath.2012.04.011.
153. Yamazaki D., Kurisu S., Takenawa T. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates. Oncogene 2009, 28:1570-1583.
154. Wolf K., te Lindert M., Krause M., Alexander S., te Riet J., et al. Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force. J. Cell Biol. 2013, 201:1069-1084. 10.1083/jcb.201210152.
155. Davies S.J.A., Fitch M.T., Memberg S.P., Hall A.K., Raisman G., et al. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 1997, 390:680-683. 10.1038/37776.
156. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mörk S., et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998, 338:278-285. 10.1056/NEJM199801293380502.
157. Merrill J.E. In vitro and in vivo pharmacological models to assess demyelination and remyelination. Neuropsychopharmacology 2009, 34:55-73. 10.1038/npp.2008.145.
158. Bhardwaj N., Kundu S.C. Electrospinning: a fascinating fiber fabrication technique. Biotechnol. Adv. 2010, 28:325-347. 10.1016/j.biotechadv.2010.01.004.
159. Christopherson G.T., Song H., Mao H.-Q. The influence of fiber diameter of electrospun substrates on neural stem cell differentiation and proliferation. Biomaterials 2009, 30:556-564. 10.1016/j.biomaterials.2008.10.004.
160. Chew S.Y., Mi R., Hoke A., Leong K.W. The effect of the alignment of electrospun fibrous scaffolds on Schwann cell maturation. Biomaterials 2008, 29:653-661. 10.1016/j.biomaterials.2007.10.025.
161. Corey J.M., Gertz C.C., Wang B.-S., Birrell L.K., Johnson S.L., et al. The design of electrospun PLLA nanofiber scaffolds compatible with serum-free growth of primary motor and sensory neurons. Acta Biomater. 2008, 4:863-875. 10.1016/j.actbio.2008.02.020.
162. Prabhakaran M.P., Venugopal J.R., Ramakrishna S. Mesenchymal stem cell differentiation to neuronal cells on electrospun nanofibrous substrates for nerve tissue engineering. Biomaterials 2009, 30:4996-5003. 10.1016/j.biomaterials.2009.05.057.
163. Johnson J., Nowicki M.O., Lee C.H., Chiocca E.A., Viapiano M.S., et al. Quantitative analysis of complex glioma cell migration on electrospun polycaprolactone using time-lapse microscopy. Tissue Eng. Part C Methods 2009, 15:531-540. 10.1089/ten.tec.2008.0486.
164. Rao S.S., Nelson M.T., Xue R., DeJesus J.K., Viapiano M.S., et al. Mimicking white matter tract topography using core-shell electrospun nanofibers to examine migration of malignant brain tumors. Biomaterials 2013, 34:5181-5190. 10.1016/j.biomaterials.2013.03.069.
165. Chen Z., Htay A., Dos Santos W., Gillies G.T., Fillmore H.L., et al. In vitro angiogenesis by human umbilical vein endothelial cells (HUVEC) induced by three-dimensional co-culture with glioblastoma cells. J. Neurooncol. 2009, 92:121-128. 10.1007/s11060-008-9742-y.
166. Hurst R.D., Fritz I.B. Properties of an immortalised vascular endothelial/glioma cell co-culture model of the blood-brain barrier. J. Cell. Physiol. 1996, 167:81-88. 10.1002/(SICI)1097-4652(199604)167:1<81::AID-JCP9>3.0.CO;2-8.
167. Zhu T.S., Costello M.A., Talsma C.E., Flack C.G., Crowley J.G., et al. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res. 2011, 71:6061-6072. 10.1158/0008-5472.CAN-10-4269.
168. Nehls V., Drenckhahn D. A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc. Res. 1995, 50:311-322. 10.1006/mvre.1995.1061.
169. Leslie-Barbick J.E., Shen C., Chen C., West J.L. Micron-scale spatially patterned, covalently immobilized vascular endothelial growth factor on hydrogels accelerates endothelial tubulogenesis and increases cellular angiogenic responses. Tissue Eng Part A 2011, 17:221-229. 10.1089/ten.TEA.2010.0202.
170. Baker B.M., Trappmann B., Stapleton S.C., Toro E., Chen C.S. Microfluidics embedded within extracellular matrix to define vascular architectures and pattern diffusive gradients. Lab Chip 2013, 13:3246-3252. 10.1039/C3LC50493J.
171. Miller J.S., Stevens K.R., Yang M.T., Baker B.M., Nguyen D.-H.T., et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat. Mater. 2012, 11:768-774. 10.1038/nmat3357.
172. Zheng Y., Chen J., Craven M., Choi N.W., Totorica S., et al. In vitro microvessels for the study of angiogenesis and thrombosis. PNAS 2012, 109:9342-9347. 10.1073/pnas.1201240109.
173. Clark A.K., Taubenberger A.V., Taylor R.A., Niranjan B., Chea Z.Y., et al. A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer. Biomaterials 2013, 34:4777-4785. 10.1016/j.biomaterials.2013.03.005.
174. Kaji H., Camci-Unal G., Langer R., Khademhosseini A. Engineering systems for the generation of patterned co-cultures for controlling cell-cell interactions. Biochim. Biophys. Acta 2011, 1810:239-250. 10.1016/j.bbagen.2010.07.002.
175. Bhatia S.N., Yarmush M.L., Toner M. Controlling cell interactions by micropatterning in co-cultures: hepatocytes and 3T3 fibroblasts. J. Biomed. Mater. Res. 1997, 34:189-199.
176. Chiu D.T., Jeon N.L., Huang S., Kane R.S., Wargo C.J., et al. Patterned deposition of cells and proteins onto surfaces by using three-dimensional microfluidic systems. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:2408-2413. 10.1073/pnas.040562297.
177. Kaji H., Kanada M., Oyamatsu D., Matsue T., Nishizawa M. Microelectrochemical approach to induce local cell adhesion and growth on substrates. Langmuir 2004, 20:16-19.
178. Yamato M., Kwon O.H., Hirose M., Kikuchi A., Okano T. Novel patterned cell coculture utilizing thermally responsive grafted polymer surfaces. J. Biomed. Mater. Res. 2001, 55:137-140.
179. Du Y., Lo E., Ali S., Khademhosseini A. Directed assembly of cell-laden microgels for fabrication of 3D tissue constructs. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9522-9527. 10.1073/pnas.0801866105.
180. Harimoto M., Yamato M., Hirose M., Takahashi C., Isoi Y., et al. Novel approach for achieving double-layered cell sheets co-culture: overlaying endothelial cell sheets onto monolayer hepatocytes utilizing temperature-responsive culture dishes. J. Biomed. Mater. Res. 2002, 62:464-470. 10.1002/jbm.10228.
181. Wong A.P., Perez-Castillejos R., Christopher Love J., Whitesides G.M. Partitioning microfluidic channels with hydrogel to construct tunable 3-D cellular microenvironments. Biomaterials 2008, 29:1853-1861. 10.1016/j.biomaterials.2007.12.044.
182. Fernandes T.G., Diogo M.M., Clark D.S., Dordick J.S., Cabral J.M.S. High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research. Trends Biotechnol. 2009, 27:342-349. 10.1016/j.tibtech.2009.02.009.
183. Alberti K., Davey R.E., Onishi K., George S., Salchert K., et al. Functional immobilization of signaling proteins enables control of stem cell fate. Nat. Methods 2008, 5:645-650. 10.1038/nmeth.1222.
184. Anderson D.G., Levenberg S., Langer R. Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat. Biotechnol. 2004, 22:863-866. 10.1038/nbt981.
185. Nakajima M., Ishimuro T., Kato K., Ko I.-K., Hirata I., et al. Combinatorial protein display for the cell-based screening of biomaterials that direct neural stem cell differentiation. Biomaterials 2007, 28:1048-1060. 10.1016/j.biomaterials.2006.10.004.
186. Kim Y., Kumar S. CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motility. Mol. Cancer Res. 2014, 10.1158/1541-7786.MCR-13-0629.
187. Wen, et al. Interplay of matrix stiffness and protein tethering in stem cell differentiation. Nat. Mater. 2014, 10.1038/nmat4051.
188. Mackay J.L., Sood A., Kumar S. Three-dimensional patterning of multiple cell populations through orthogonal genetic control of cell motility. Soft Matter 2014, 10:2372-2380.
189. Rape A.D., Kumar S. A composite hydrogel platform for the dissection of tumor cell migration at tissue interfaces. Biomaterials 2014, 35(31):8846-8853.